The current issue of the UK Medicines Control Agency's MAIL publicationreminds companies that it is an offense to advertise prescription-only medicines to the public on the Internet, or to use it for advertising unlicensed drugs or unlicensed indications for licensed products.
These prohibitions are contained within the Medicines (Advertising) Regulations 1994 and the Medicines (Monitoring of Advertising) Regulations of 1994, which implement European Union Directive 92/28/EEC. Moreover, the Codes of Practice for POM and over-the-counter medicines administered by the Prescription Medicines Code of Practice Authority and the Proprietary Association of Great Britain apply to the Internet, and are being updated to state this explicitly, it says.
MAIL notes that as global controls on Internet activities relevant to drugs are required, where necessary, to protect public health, the MCA is working with other regulatory authorities and participating in the World Health Organization Working Group on cross-border advertising, promotion and sale of medicinal products via the Internet.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze